| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SGEN | Common Stock | Options Exercise | $1,938,523 | +42,793 | +37% | $45.30 | 159,978 | 09 Mar 2023 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | $1,804,983 | -10,262 | -6.4% | $175.89 | 149,716 | 09 Mar 2023 | Direct | F1, F2, F3 |
| transaction | SGEN | Common Stock | Sale | $4,673,803 | -26,449 | -18% | $176.71 | 123,267 | 09 Mar 2023 | Direct | F1, F2, F4 |
| transaction | SGEN | Common Stock | Sale | $1,078,764 | -6,082 | -4.9% | $177.37 | 117,185 | 09 Mar 2023 | Direct | F1, F2, F5 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -42,793 | -100% | $0.000000* | 0 | 09 Mar 2023 | Common Stock | 42,793 | $45.30 | Direct | F6 |
| Id | Content |
|---|---|
| F1 | Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. |
| F2 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. |
| F3 | Reflects sales of common stock executed in multiple transactions at prices ranging from $175.19 to $176.18. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F4 | Reflects sales of common stock executed in multiple transactions at prices ranging from $176.19 to $177.19. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F5 | Reflects sales of common stock executed in multiple transactions at prices ranging from $177.19 to $177.59. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F6 | Options vested at a rate of 25% on 8/27/17 and monthly thereafter until all the options were fully vested on 8/27/20. |